Jump Financial, LLC Fulgent Genetics, Inc. Transaction History

Jump Financial, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$19.6 - $25.06 $410,032 - $524,255	-20,920 Closed	0 $0
Q2 2024 Aug 14, 2024	SELL	$19.09 - $22.57 $215,354 - $254,612	-11,281 Reduced 35.03%	20,920 $410,000
Q1 2024 May 13, 2024	BUY	$21.55 - $29.29 $693,931 - $943,167	32,201 New	32,201 $698,000
Q4 2021 Feb 10, 2022	SELL	$77.3 - $105.0 $796,112 - $1.08 Million	-10,299 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$74.87 - $110.87 $148,092 - $219,300	-1,978 Reduced 16.11%	10,299 $927,000
Q2 2021 Aug 13, 2021	BUY	$66.8 - $100.45 $820,103 - $1.23 Million	12,277 New	12,277 $1.13 Million
Q1 2021 May 17, 2021	SELL	$59.3 - $183.85 $477,365 - $1.48 Million	-8,050 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$31.01 - $52.1 $249,630 - $419,405	8,050 New	8,050 $419,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.